ICU Medical (NSDQ:ICUI) posted third-quarter results today that beat the consensus on Wall Street.
The San Clemente, Calif.-based company reported profits of $26.6 million, or $1.24 per share, on sales of $307.5 million for the three months ended Sept. 30, 2019, for a bottom-line gain of 12046.1% sales loss of -6% compared with Q3 2018.
Adjusted to exclude one-time items, earnings per share were $1.65, 3¢ ahead of The Street, where analysts were looking for sales of $297.8 million.
“Third-quarter revenue, adjusted EBITDA and adjusted diluted earnings per share were generally in line with our expectations,” CEO Vivek Jain said in a news release.
The company also announced earlier this month that it would acquire Pursuit Vascular for $75 million.
Shares in ICUI were up 0.79% to $180.09 apiece in mid-morning trading.